FutureDx Summit 2026 · Point-of-Care Testing
Be Where Point-of-Care Testing Happens
Point-of-care testing is moving diagnostics out of the central lab and across the NHS. FutureDx Summit 2026 puts the coordinators, clinicians, and lab leads who deploy it in one validated room.
P.S. Near-patient analysers, connectivity, or rapid molecular, if it tests at the point of care, your buyers are here.
No instant download. A senior member of the team replies personally.
What Is Point-of-Care Testing (POCT)?
Point-of-care testing (POCT) is diagnostic testing performed at or near the patient — at the bedside, in clinic, or in the community — rather than in a central laboratory, giving clinicians results in minutes.
Point-of-care testing is a core theme at FutureDx Summit 2026, spanning rapid infection tests, lateral flow, molecular POCT and connectivity into NHS systems, on 27–28 October 2026 in London.
The reach
Where Point-of-Care Testing Happens
POCT is no longer confined to the lab. It runs everywhere care is delivered, and a buyer sits behind each setting.
Emergency Departments
Rapid results to speed urgent decisions.
Hospital Wards
Testing carried out at the bedside.
GP and Primary Care
Diagnosis closer to first contact.
Community Clinics
Closer to where patients live.
Pharmacies
Accessible front-line testing.
Care Homes
Testing for vulnerable populations.
Why now
Point-of-Care Testing Is Growing Fast
Three shifts are pushing testing outward, and all three create demand for the right POCT solutions.
Pressure on Central Labs
Capacity and turnaround push testing closer to the patient.
Care Is Moving Closer to Home
Community and primary care need diagnostics on site.
Demand for Speed
Near-patient results change decisions in minutes, not days.
The decision
What POCT Buyers Evaluate
POCT is bought on more than the test itself. Speak to these five questions and you speak the buyer’s language.
Connectivity and Middleware
Results flowing cleanly into the LIMS and patient record.
Quality and Governance
Meeting ISO 15189 and ISO 22870, with clear oversight.
Ease of Use
Reliable in the hands of non-laboratory staff.
Throughput and Reliability
Performance that holds up in a busy setting.
Support and Total Cost
Training, servicing, and the real cost of ownership.
Clinical Evidence
Data the governance committee can stand behind.
The buyers
Who Owns POCT Decisions
POCT is a shared decision across the trust. FutureDx puts the whole group in one room.
Agenda fit
POCT Across the Programme
The sessions your buyers came for map straight onto what you sell.
The room
Senior, Validated, and On-Topic
A small room, but the right one: the people who deploy and govern point-of-care testing across the NHS.
Delegate Seniority
The Whole POCT Decision, In One Room
The coordinator who runs the service, the governance lead who signs it off, the informatics team who connects it, and the clinician who uses it, all validated before they register. With pre-arranged meetings you can reach the group that adopts POCT in two days. See how the 1:1 meetings programme works.
Questions
POCT Sponsorship, Answered
Is point-of-care testing on the FutureDx agenda?
Yes. POCT runs across the programme, from decentralised and near-patient testing to connectivity and middleware, quality and governance, community diagnostics, and rapid point-of-care testing for sepsis and AMR. It is one of the core themes the audience comes for.
Who attends that buys point-of-care testing?
The people who deploy and govern POCT across the NHS: POCT coordinators, lab directors and POCT governance leads, primary care and community leads, emergency and ward clinical leads, informatics and IT teams, and procurement leads. More than 60% are at VP level and above, and every delegate is validated before they register.
What do POCT buyers actually evaluate?
Connectivity and middleware so results flow into the LIMS and patient record, quality and governance against ISO 15189 and ISO 22870, ease of use in the hands of non-laboratory staff, throughput and reliability in a busy setting, and the support and total cost of ownership. The agenda and the audience are built around exactly these questions.
My product is a near-patient analyser or connectivity platform. Is this the right room?
Yes. Near-patient analysers, rapid molecular POC, and connectivity or middleware platforms all map directly onto the agenda and the audience. You will be in front of the POCT coordinators, governance leads, and informatics teams who evaluate and adopt them.
How do we get in front of the POCT audience?
Through a sponsorship package or the standalone 1:1 Meetings programme. Each tier includes a set number of pre-arranged meetings, so you can book time with the specific POCT coordinators, governance leads, and primary care decision-makers you want to reach. Request the sponsor pack for the options and pricing.
It is the inaugural edition. Is it worth it for POCT?
The specialist format is well established at comparable diagnostics events, and FutureDx applies it to a deliberately small, senior, validated room. Being first also means owning the association with the UK’s dedicated diagnostics summit as point-of-care testing expands across the NHS.
When and where is FutureDx Summit 2026 held?
FutureDx Summit 2026 runs across two days on 27 and 28 October 2026 in London, UK, with a drinks reception on Day 1.
Reach the POCT audience
Get In Front of the People Who Deploy POCT
Send your details and a senior member of the team replies with the audience breakdown, how your POCT solution fits the agenda, the packages, and pricing.
- The coordinators and governance leads who adopt POCT
- Pre-arranged meetings with the buyers you choose
- A reply from a person, not an autoresponder
P.S. Compare the sponsorship packages or the 1:1 Meetings programme.
A Point-of-Care Diagnostics Conference for the NHS
Is FutureDx a point-of-care diagnostics conference?
Yes. FutureDx Summit 2026 is a point-of-care diagnostics conference theme, covering rapid, lateral flow and molecular POCT. London, 27–28 October 2026, with 150+ NHS and industry buyers.
Is there a point of care testing conference in Europe in 2026?
FutureDx Summit 2026 is a point of care testing conference held in London, Europe, on 27–28 October 2026, covering rapid and molecular POCT for NHS and European buyers.
Point of Care Testing Conference Europe
FutureDx Summit 2026 is a Point of Care Testing Conference Europe attendees reach in London, on 27–28 October 2026.